(Q41115413)

English

MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats

scientific article published on May 1992

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1 reference

based on heuristic

inferred from title

author name string

Sonsalla PK

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Zeevalk GD

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Manzino L

3

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Giovanni A

4

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Nicklas WJ

5

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

language of work or name

0 references

publication date

1 May 1992

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

58

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1979-1982

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB10081.X

21 January 2018

Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB10081.X

21 January 2018

The biodisposition of MPP+ in mouse brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB10081.X

21 January 2018

Excitatory amino acid neurotoxicity and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB10081.X

21 January 2018

Correlation of MPTP neurotoxicity in vivo with oxidation of MPTP by the brain and blood-brain barrier in vitro in five rat strains

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB10081.X

21 January 2018

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB10081.X

21 January 2018

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1992.TB10081.X

21 January 2018

Identifiers

10.1111/J.1471-4159.1992.TB10081.X

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41115413&oldid=2094056023"